Wnt5a: a potential factor linking psoriasis to metabolic complications

Area of Science:

• Dermatology and Metabolic Health
• Molecular Biology and Endocrinology

Background:

• Psoriasis is frequently linked with metabolic comorbidities such as obesity, insulin resistance, and type 2 diabetes mellitus.
• The protein wingless-type MMTV integration site Family, Member 5a (wnt5a), released from adipose tissue macrophages in obesity, plays a role in insulin resistance development.
• Wnt5a is also found to be upregulated in psoriatic skin lesions, suggesting a potential connection to the disease.

Purpose of the Study:

• To investigate alterations in circulating wingless-type MMTV integration site Family, Member 5a (wnt5a) and secreted frizzled-related protein 5 (sFRP5) in psoriasis patients.
• To compare wnt5a and sFRP5 levels in lean and obese psoriasis patients against lean and obese healthy controls.

Main Methods:

• Serum concentrations of wnt5a and sFRP5 were measured in four groups: lean psoriasis patients, obese psoriasis patients, lean healthy controls, and obese healthy controls.
• Statistical analysis was performed to compare protein levels between patient and control groups.

Main Results:

• Serum wnt5a levels were significantly higher in lean psoriasis patients compared to lean healthy controls (P ≤ 0.01).
• Serum wnt5a levels were also significantly elevated in obese psoriasis patients compared to obese healthy controls (P ≤ 0.001).
• No specific results were mentioned for sFRP5 in the abstract.

Conclusions:

• The study suggests that increased circulating wnt5a may contribute to the development of metabolic comorbidities in patients with psoriasis.
• This finding highlights a potential molecular link between psoriasis and metabolic disturbances.